Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Clin Cancer Res. 2020 Jan 22;26(11):2595–2602. doi: 10.1158/1078-0432.CCR-19-1669

Table 2.

Percent genome alteration in JHMI AA cohort (n=205) and TCGA cohort (n=313) by pathologic grade.

JHMI AA (n=205) TCGA AA (n=43) TCGA EA (n=270)

PGA, median (IQR) p-value PGA, median (IQR) p-value PGA, median (IQR) p-value

Total 3.74 (0.93–9.35) 6.48 (0.45–12.34) 0.877^ 6.08 (1.74–11.71)

RP grade group <0.001* <0.001* <0.001*
  1 0.94 (0–4.21) 0.61 (0.004–6.39) 0.486^ 2.11 (0.05–4.99)
  2 1.87 (0–3.27) 3.89 (0.09–7.53) 0.480^ 4.68 (1.36–7.94)
  3 3.74 (0.94–10.28) 9.57 (6.34–16.73) 0.154^ 6.94 (2.68–11.38)
  4 8.41 (2.80–11.22) 12.03 (8.86–15.51) 0.780^ 13.74 (7.40–22.20)
  5 4.67 (0.94–9.35) 26.2 (15.2–34.9) 0.032^ 8.97 (3.53–17.90)
*

P-value signifies Kruskal Wallis calculation to detect differences in PGA between grade groups within each cohort.

^

P-value signifies rank sum calculation to detect differences in PGA between TCGA AA and TCGA EA cohorts within each grade group.